The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir
Agreement seeks to improve health options for hepatitis C patients in low- and middle-income countries [Medicines Patent Pool Press Release, Link] Amsterdam, Netherlands, 21 April 2017 —The Medicines Patent Pool (MPP) announced a new licence and technology transfer agreement…